Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 April 2008, Vol. 111, No. 8, pp. 4055-4063.
Prepublished online as a Blood First Edition Paper on November 9, 2007; DOI 10.1182/blood-2007-05-091710.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2007-05-091710v1
111/8/4055    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jokubaitis, V. J
Right arrow Articles by Simmons, P. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jokubaitis, V. J
Right arrow Articles by Simmons, P. J
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 22, 2007
Accepted October 15, 2007

Angiotensin-Converting Enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal and adult hematopoietic tissues

Vanta J Jokubaitis, Lidia Sinka, Rebecca Driessen, Genevieve Whitty, David N Haylock, Ivan Bertoncello, Ian Smith, Bruno Peault, Manuela Tavian, and Paul J Simmons*

Stem Cell Biology Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
INSERM U602, Villejuif, France
Australian Stem Cell Centre, Clayton, Victoria, Australia
Research Laboratory, Baker Institute, Prahran, Victoria, Australia
Rangos Research Center, Children's Hospital, Pittsburgh, PA, United States
Faculte de Medecine, Universite Paris-Sud, Villejuif, France
Brown Foundation Institute of Molecular Medicine (IMM), University of Texas Health Science Centre, Houston, TX, United States

* Corresponding author; email: paul.j.simmons{at}uth.tmc.edu.

Previous studies revealed that mAb BB9 reacts with a subset of CD34+ human BM cells with hematopoietic stem cell (HSC) characteristics. Here we map BB9 expression throughout hematopoietic development and show that the earliest definitive HSC that arise at the ventral wall of the aorta and surrounding endothelial cells are BB9+. Thereafter, BB9 is expressed by primitive hematopoietic cells in fetal liver and in umbilical cord blood (UCB). BB9+CD34+ UCB cells transplanted into NOD/SCID mice contribute 10-fold higher numbers of multi-lineage blood cells than their CD34+BB9- counterparts and contain a significantly higher incidence of SCID-repopulating cells than the unfractionated CD34+ population. Protein micro-sequencing of the 160kDa band corresponding to the BB9 protein established its identity as that of somatic Angiotensin Converting Enzyme (ACE). Although the role of ACE on human HSC remains to be determined, these studies designate ACE as a hitherto unrecognized marker of human HSC throughout hematopoietic ontogeny and adulthood.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

BB9 ACEs the HSC compartment
Mervin C. Yoder
Blood 2008 111: 3912. [Full Text] [PDF]



This article has been cited by other articles:


Home page
haematolHome page
T. S. Park and E. T. Zambidis
A role for the renin-angiotensin system in hematopoiesis
Haematologica, June 1, 2009; 94(6): 745 - 747.
[Full Text] [PDF]


Home page
J. Immunol.Home page
F. Timmermans, I. Velghe, L. Vanwalleghem, M. De Smedt, S. Van Coppernolle, T. Taghon, H. D. Moore, G. Leclercq, A. W. Langerak, T. Kerre, et al.
Generation of T Cells from Human Embryonic Stem Cell-Derived Hematopoietic Zones
J. Immunol., June 1, 2009; 182(11): 6879 - 6888.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Yokota, K. Oritani, S. Butz, K. Kokame, P. W. Kincade, T. Miyata, D. Vestweber, and Y. Kanakura
The endothelial antigen ESAM marks primitive hematopoietic progenitors throughout life in mice
Blood, March 26, 2009; 113(13): 2914 - 2923.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. T. Zambidis, T. Soon Park, W. Yu, A. Tam, M. Levine, X. Yuan, M. Pryzhkova, and B. Peault
Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells
Blood, November 1, 2008; 112(9): 3601 - 3614.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
S. D. Nimer
MDS: A Stem Cell Disorder--But What Exactly Is Wrong with the Primitive Hematopoietic Cells in This Disease?
Hematology, January 1, 2008; 2008(1): 43 - 51.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020